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Background
Cardiac T2 mapping has been suggested for monitoring
of acute allograft rejection, since the T2 relaxation time
increases with myocardial edema [1]. Besides its non-
invasive nature, the main advantage of T2 mapping over
the reference standard endomyocardial biopsy (EMB) is
that it results in a higher spatial coverage of the myocar-
dium. Currently established 2D techniques are used to
acquire several slices in short- and long-axis orientation,
which should suffice for the detection of moderate to
severe rejection (ISHLT degree 2R-3R [2]), since the
manifestation of edema is global. However, in the case
of the more common mild rejection, the manifestation
of edema is localized and patchy, and might thus be
missed by a selective 2D visualization. We therefore
investigated the performance of a novel 3D cardiac T2
mapping technique [3] for the detection of acute allo-
graft rejection versus 2D T2 mapping and EMB.
Methods
28 Patients (age 54 ± 12 y, 24 males) underwent routine
EMB as well as 2D and 3D cardiac T2 mapping at 3T.
Navigator-gated 2D T2 maps [4] (voxel size 1.2 × 1.2 ×
5 mm3) in 3 short-axis slices and a prototype self-navi-
gated 3D radial whole-heart isotropic T2 map [3] (voxel
size 1.7 mm3) were acquired with 3 T2-preparation
durations and free breathing. After reformatting of the
3D T2 maps and matching for slice thickness, the 2D
and 3D T2 maps at the same location were segmented
according to AHA guidelines [5]. The highest segmental
2D and 3D T2 values of each patient were compared
statistically, and then divided into groups according to
their EMB rejection degree. These groups were then
tested for differences in T2 value. The 3D T2 maps were
furthermore directly rendered in 3D, after which they
were inspected for foci of T2 elevation.
Results
EMB analysis indicated allograft rejection in 3 out of
28 cases (i.e. 25 × 0R, 2 × 1R and 1 × 2R). The highest
2D segmental T2 values of the groups were 49.9 ± 4.0
ms (0R), 48.9 ± 0.8 ms (1R), and 65.0 ms (2R). The
reformatted 3D T2 values agreed very well with the 2D
T2 values for all patients (p = 0.84, Figure 1). While
neither of the 1R cases demonstrated significantly ele-
vated segmental T2 in the 2D or 3D T2 maps, foci of
elevated T2=58.2 ± 3.6 ms that were not visible on the
2D T2 maps could be clearly identified in both their
rendered 3D T2 maps (Figure 1B, black arrow).
Conclusions
The investigated 3D cardiac T2 mapping agreed with the
established 2D technique, and enables the identification
of foci of elevated T2 in regions of the myocardium that
are not covered by the 2D technique. The 3D cardiac T2
mapping technique thus appears to be well-suited for the
investigation of mild allograft rejection (degree 1R), but
this remains to be confirmed in a larger patient cohort.
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Figure 1 3D & 2D T2 maps of cardiac allograft rejection. A-C) Examples of rendered 3D T2 maps that were segmented along the center of
the endocardium. D-F) Corresponding basal 2D T2 maps. While the segmental T2 values in 2D T2 maps of the patients with mild rejection as
determined through EMB were not elevated, the corresponding 3D T2 maps contained myocardial regions with significantly elevated T2 values
(black arrow). The color bar indicates T2 values in ms for all maps.
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